Frontiers in Oncology (Oct 2020)

The Role of Tumor Deposits in Predicting the Efficacy of Chemotherapy in Stage III Colon Cancer

  • Mingyu Shi,
  • Hongzhi Zhang,
  • Guozhong Yao,
  • Jianjun Wu,
  • Chuming Zhu,
  • Xu Zhang,
  • Yuan Ren

DOI
https://doi.org/10.3389/fonc.2020.586603
Journal volume & issue
Vol. 10

Abstract

Read online

PurposeTo evaluate the role of tumor deposits (TDs) in predicting the efficacy of chemotherapy in stage III colon cancer.MethodsUsing the SEER∗Stat software Version 8.3.6, we started with a national cohort of colon cancer cases diagnosed between 2004 and 2016. We used the χ2 (Chi-square) test to compare differences between different categorical variables according to the number of TDs. The Cox proportional hazards regression model was used to determine the independent association of different clinical and pathological variables with CSS, which were adjusted for other significant prognostic factors.ResultsWe have identified 29,017 patients diagnosed with stage III colon cancer from the SEER database. The results of multivariate analyses showed that patients with the receipt of chemotherapy had 54.7% decreased risk of cancer-specific mortality compared with those not (HR = 0.453, 95% CI = 0.425–0.483, P < 0.0001) in the no-TD group; In the 1–2-TD group, patients with the receipt of chemotherapy had 56.8% decreased risk of cancer-specific mortality compared with those not (HR = 0.432, 95% CI = 0.364–0.512, P < 0.0001); In the ≥3-TD group, patients with the receipt of chemotherapy had 51.8% decreased risk of cancer-specific mortality compared with those not (HR = 0.482, 95% CI = 0.389–0.597, P < 0.0001).ConclusionsOur study demonstrated that the presence of TDs was associated with a dismal prognosis and high number of TDs would also contribute to the worse survival of colon cancer. High number of TDs did not affect the survival benefit of chemotherapy in stage III colon cancer.

Keywords